Transactions
Nov. 18, 2003
Biotech IPOs Continue; Investors Are Unimpressed
A steady stream of biotechnology companies braved the public markets over the past several weeks, but the newcomers failed to generate much excitement among investors.
Eight biotechnology companies have launched initial public offerings since the beginning of the year. Seven, including two California companies, hit t...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In